000 01139 a2200325 4500
005 20250516071837.0
264 0 _c20120606
008 201206s 0 0 eng d
022 _a1874-4729
024 7 _a10.2174/1874471011104030197
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aOlafsen, Tove
245 0 0 _aProtein targeting constructs in alpha therapy.
_h[electronic resource]
260 _bCurrent radiopharmaceuticals
_cJul 2011
300 _a197-213 p.
_bdigital
500 _aPublication Type: Journal Article; Review
650 0 4 _aAlpha Particles
_xtherapeutic use
650 0 4 _aAntibodies, Monoclonal
_xtherapeutic use
650 0 4 _aHalf-Life
650 0 4 _aHumans
650 0 4 _aNeoplasms
_xradiotherapy
650 0 4 _aProtein Transport
650 0 4 _aRadioimmunotherapy
_xmethods
650 0 4 _aRadioisotopes
_xtherapeutic use
650 0 4 _aRadiopharmaceuticals
_xtherapeutic use
700 1 _aElgqvist, Jorgen
700 1 _aWu, Anna M
773 0 _tCurrent radiopharmaceuticals
_gvol. 4
_gno. 3
_gp. 197-213
856 4 0 _uhttps://doi.org/10.2174/1874471011104030197
_zAvailable from publisher's website
999 _c21421742
_d21421742